Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_assertion type Assertion NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_head.
- NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_assertion description "[In this study, a total of 61 patients with PCa and 10 patients with benign prostatic hyperplasia were included, and we showed that the expression of SFRP1 and ?-catenin was correlated with the Gleason score, survival rate and response for endocrine therapy of PCa.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_provenance.
- NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_assertion evidence source_evidence_literature NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_provenance.
- NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_assertion SIO_000772 25719802 NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_provenance.
- NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_assertion wasDerivedFrom befree-2016 NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_provenance.
- NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_assertion wasGeneratedBy ECO_0000203 NP1266451.RA4kGO0I0XBDe1NR8QPddIHBhsjbyDjfwjMu9FuC5eGUw130_provenance.